Brind.

Tilray published pioneering research on cannabinoid pharmacokinetics.

1 report, 0 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Tilray

Keep exploring

The entities involved

Tilray
pharmaceutical and cannabis company
- Both InterCure and Tilray are small-cap healthcare providers.Sun 20:47
- Potential agreement for Carlsberg beer products in the U.S.Wed 19:47

Coverage

Newest first; wire copies grouped

Jun 26Unknown outlet